Recent research further suggests that Chi3l1 can be differentially expressed in various respiratory tract diseases, such as asthma, COPD, and asthma–COPD overlap syndrome (ACO) and that it functions in predicting the loss of lung function and neutrophilic airway inflammation in patients with these diseases [44,45]. This evidence concerns the gene CHI3L1 and asthma.